Clinicians Are Increasingly Left with Few...
Specializing in Showing Biotech or Biopharma...
Tools for Assessing Treatments Offer Separate,...
Cell Culture Requirements Are Not Only...
For full access to this article login to GEN Select now.
On this year’s list, the minimum market cap is just under $8 billion—a big jump from the $2.92 billion minimum from last year’s list.
The rich are getting richer when it comes to publicly traded biotechnology companies, judging by their ballooning market capitalization. It’s a product of the ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
What do you consider the greatest threat to your career prospects?
Be sure to add firstname.lastname@example.org
to your Address Book or Safe Senders List.
here for instructions.
If you have any questions about your subscription, click
here to email us or call at (914) 740-2189.
You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
© 2015 Genetic Engineering & Biotechnology News All Rights Reserved